ZSAN stock forecast
Our latest prediction for Zosano Pharma Corp.'s stock price was made on the Feb. 27, 2018 when the stock price was at 8.29$.
In the short term (2weeks), ZSAN's stock price should underperform the market by -2.12%. During that period the price should oscillate between -15.33% and +24.54%.
In the medium term (3months), ZSAN's stock price should underperform the market by -1.17%. During that period the price should oscillate between -29.24% and +53.28%.Get email alerts
About Zosano Pharma Corp.
Zosano Pharma Corp. is a clinical stage pharmaceutical company, which engages in the provision of systemic administration of therapeutics to patients. It offers Qtrypta, a drug used orally and nasally to effectively and safely treat acute migraine. The company was founded in January 2012 and is headquartered in Fremont, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -3.74$ per share.
The book value per share is 3.01$
Three months stock forecastFeb. 27, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|